Loparex has promoted Anthony Woods to Chief Commercial Officer, giving him oversight of the release liner maker's global commercial organisation. Woods joined Loparex in 2020 and most recently served as Head of Market and Technology, having previously spent 15 years at ICI and AkzoNobel.
Why this mattersCommercial responsibility across Loparex's global release liner business passes to its former head of market and technology, concentrating account and product strategy under one role.
- Loparex announced the appointment of Anthony Woods as Chief Commercial Officer on 5 October 2026
- Woods will oversee Loparex's global commercial organisation
- He joined Loparex in 2020 as Market Director of the Graphic and Label business
- He most recently held the role of Head of Market and Technology at Loparex
- He previously spent 15 years at ICI and AkzoNobel, including six years in Industrial Wood Finishes and Adhesives leadership
- He holds a PhD in Chemistry from the University of Cambridge
Monarch Alternative Capital and General Atlantic are to take majority control of coated-paper maker Loparex through a restructuring of roughly USD 1bn that allows the company to avoid a bankruptcy filing. The deal removes more than USD 400m of liabilities by converting about half of Loparex's first-lien debt into equity and wiping out a junior loan held by Blue Owl Capital. Loparex receives around USD 80m of new equity capital.
Why this mattersThe debt-for-equity swap shows lenders absorbing losses to keep a mid-size specialty paper supplier out of bankruptcy, a bellwether for leveraged packaging-adjacent credits.
- Restructuring is valued at roughly USD 1bn
- More than USD 400m of liabilities will be shed from Loparex's balance sheet
- About half of the company's first-lien debt will be swapped for equity
- A junior loan held by Blue Owl Capital will be wiped out
- Loparex will receive around USD 80m in new equity capital
- Monarch Alternative Capital and General Atlantic will own the majority of the restructured company
Release liner maker Loparex is moving to a new ownership structure as part of a comprehensive recapitalisation, under which it announced a further investment at the beginning of September 2026. According to trade publication EUWID, that investment is to be made by Monarch Alternative Capital. Loparex, which produces silicone-coated release liners, is based in Cary, North Carolina.
Why this mattersA change of ownership at an internationally active silicone-coated release liner producer sets who funds capex on an input every pressure-sensitive label converter buys.
- Loparex announced a further investment at the beginning of September 2026 as part of a comprehensive recapitalisation
- The investment is to be made by Monarch Alternative Capital
- The recapitalisation gives Loparex a new ownership structure
- Loparex is headquartered in Cary, North Carolina, and makes silicone-coated release liners
